Inovio Pharmaceuticals
INO
INO
103 hedge funds and large institutions have $20.7M invested in Inovio Pharmaceuticals in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 30 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
14% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 28
27% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 30
Holders
103
Holding in Top 10
–
Calls
$1.4M
Puts
$94K
Top Buyers
| 1 | +$706K | |
| 2 | +$574K | |
| 3 | +$349K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$344K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$332K |
Top Sellers
| 1 | -$3.62M | |
| 2 | -$2.32M | |
| 3 | -$845K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$833K |
| 5 |
State Street
Boston,
Massachusetts
|
-$795K |
